118 related articles for article (PubMed ID: 29575128)
1. Synchronous mantle cell lymphoma and lung adenocarcinoma presenting in a pleural effusion: A rare tumour combination and a potential pitfall of cytodiagnosis.
Kai K; Ryu Y; Kamochi K; Nishioka A; Kubota Y; Nakamura M; Kimura S; Sueoka E; Aishima S
Cytopathology; 2018 Aug; 29(4):400-402. PubMed ID: 29575128
[No Abstract] [Full Text] [Related]
2. Synchronous malignancies detected by effusion cytology.
Sur N; Silverman JF
Diagn Cytopathol; 1998 Mar; 18(3):184-7. PubMed ID: 9523135
[TBL] [Abstract][Full Text] [Related]
3. A rare tumoral combination, synchronous lung adenocarcinoma and mantle cell lymphoma of the pleura.
Hatzibougias D; Bobos M; Karayannopoulou G; Karkavelas G; Karapanagiotidis GT; Foroulis CN; Kostopoulos I
World J Surg Oncol; 2008 Dec; 6():137. PubMed ID: 19114021
[TBL] [Abstract][Full Text] [Related]
4. "Single-cell pattern" of adenocarcinoma cells in effusion cytology: Morphologic challenges of lung cancer.
Guleria P; Barwad A; Malik PS; Madan K; Jain D
Diagn Cytopathol; 2021 Jan; 49(1):77-82. PubMed ID: 32818307
[TBL] [Abstract][Full Text] [Related]
5. Pericardial, pleural and peritoneal involvement in a patient with primary gastric mantle cell lymphoma.
Keklik M; Yildirim A; Keklik E; Ertan S; Deniz K; Ozturk F; Ileri I; Cerci I; Camlica D; Cetin M; Eser B
Scott Med J; 2015 May; 60(2):e21-4. PubMed ID: 25636307
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic efficacy of electron microscopy and pleural effusion cytology for the distinction of pleural mesothelioma and lung adenocarcinoma.
Domínguez-Malagón H; Cano-Valdez AM; González-Carrillo C; Campos-Salgado YE; Lara-Garcia A; Lopez-Mejia M; Corona-Cruz JF; Arrieta O
Ultrastruct Pathol; 2016; 40(5):254-60. PubMed ID: 27405014
[TBL] [Abstract][Full Text] [Related]
7. Synchronous mantle cell lymph node lymphoma and pulmonary adenocarcinoma: a case report with literature review.
Braham E; Zarrouk M; Mlika M; Kilani T; El Mezni F
Clin Respir J; 2017 Jul; 11(4):430-432. PubMed ID: 26256690
[TBL] [Abstract][Full Text] [Related]
8. Synchronous primary pulmonary lymphoma presenting with pulmonary adenocarcinoma: A case report and literature review.
Zheng JX; Li XZ; Xiang RL; Gao Z
Indian J Cancer; 2015 Nov; 52 Suppl 1():e37-40. PubMed ID: 26548938
[TBL] [Abstract][Full Text] [Related]
9. Mammalian target of rapamycin (mTOR) inhibition does not prevent lung adenocarcinoma-induced malignant pleural effusion.
Vazakidou ME; Magkouta S; Moschos C; Kalomenidis I
Respirology; 2014 Feb; 19(2):290-292. PubMed ID: 23819792
[TBL] [Abstract][Full Text] [Related]
10. Primary tumour resection showed survival benefits for non-small-cell lung cancers with unexpected malignant pleural dissemination.
Ren YJ; She YL; Dai CY; Jiang GN; Fei K; Chen C
Interact Cardiovasc Thorac Surg; 2016 Mar; 22(3):321-6. PubMed ID: 26705302
[TBL] [Abstract][Full Text] [Related]
11. Exosomal MicroRNA Expression Profiling in Patients with Lung Adenocarcinoma-associated Malignant Pleural Effusion.
Tamiya H; Mitani A; Saito A; Ishimori T; Saito M; Isago H; Jo T; Yamauchi Y; Tanaka G; Nagase T
Anticancer Res; 2018 Dec; 38(12):6707-6714. PubMed ID: 30504380
[TBL] [Abstract][Full Text] [Related]
12. Calretinin immunostaining in benign and malignant pleural effusions.
Simsir A; Fetsch P; Abati A
Diagn Cytopathol; 2001 Feb; 24(2):149-52. PubMed ID: 11169899
[No Abstract] [Full Text] [Related]
13. Molecular Alterations in Patients with Pulmonary Adenocarcinoma Presenting with Malignant Pleural Effusion at the First Diagnosis.
Rodriguez EF; Shabihkhani M; Carter J; Maleki Z
Acta Cytol; 2017; 61(3):214-222. PubMed ID: 28538219
[TBL] [Abstract][Full Text] [Related]
14. [Application of immunocytochemistry in exfoliative cytology samples].
Pan L; Gao FY; Guo YR
Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):491-3. PubMed ID: 17845766
[No Abstract] [Full Text] [Related]
15. Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion.
Tsai TH; Wu SG; Hsieh MS; Yu CJ; Yang JC; Shih JY
Lung Cancer; 2015 May; 88(2):208-14. PubMed ID: 25773866
[TBL] [Abstract][Full Text] [Related]
16. Transformation from lung adenocarcinoma to combined small cell carcinoma in pleural effusion after treatment with osimertinib.
Frankel D; Kaspi E; Liprandi A; Dales JP; Roll P
Cytopathology; 2022 Sep; 33(5):633-635. PubMed ID: 35689552
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of bevacizumab combined with chemotherapy in lung adenocarcinoma-induced malignant pleural effusion.
Tao H; Meng Q; Li M; Shi L; Tang J; Liu Z
Thorac Cancer; 2018 Feb; 9(2):298-304. PubMed ID: 29297985
[TBL] [Abstract][Full Text] [Related]
18. Prognosis of non-small-cell lung cancer patients with positive pleural lavage cytology.
Nakao M; Hoshi R; Ishikawa Y; Matsuura Y; Uehara H; Mun M; Nakagawa K; Okumura S
Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):777-82. PubMed ID: 25762707
[TBL] [Abstract][Full Text] [Related]
19. Synchronic Diagnosis of Non-Hodgkin Lymphoma and Lung Adenocarcinoma via EBUS-guided TBNA.
Samuel G; Simoff M; Chaabaan S; Diaz-Mendoza J
J Bronchology Interv Pulmonol; 2018 Jul; 25(3):e41-e42. PubMed ID: 29944597
[No Abstract] [Full Text] [Related]
20. Extensive Emperipolesis of Neoplastic Lymphocytes by Mesothelial Cells in Pleural Effusion Cytology in a Case of a Mediastinal T-Cell Lymphoblastic Lymphoma: A Rare but Diagnostically Useful Phenomenon.
Haefliger S; Rebetez J; Buser PJ; Dirnhofer S; Bubendorf L
Acta Cytol; 2020; 64(3):274-278. PubMed ID: 31527381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
